CAS: 830-89-7; Albutoin

该化合物是一种环环状化合物,具有二位功能组,具有硫离子(C=S)功能组的异氨基碘内核,分子在五位和三位(丙基-2-en-1-yl) 的直基(丙基-2-en-1-yl)-3-(丙基-2-en-1-1-yl)--2--2-sulfanfannidenadazolidin-4 one 1-1-one 1-one 是一个环球状化合物,它作为协调化学和制药衍生的离子体或中间体,其结构特征,包括不饱和异的异基组,可以通过交叉组合或添加反应促进进一步的功能化.该化合物的稳定性和定义的立体电子特性使其适合于医学和材料科学的探索研究.

结构式图片

相似化合物

436855-68-4 53517-95-6 55523-05-2

欧盟法规

C&L通报

合成工艺路线路线简述

  • 合成目标产物 Albutoin 主要起始原料 Dl-Leucine
  • (文献来源)合成步骤主要原料 Dl-Leucine
📜Dl-亮氨酸置于吡啶,水,达卡巴嗪,三乙胺,N,N-二异丙基乙胺体系中,用 二氯甲烷,水,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 28.0H,反应生成 阿布妥因
参考文献:Thiourea Modified Doxorubicin: A Perspective Ph-Sensitive Prodrug
标题:Thiourea Modified Doxorubicin: A Perspective Ph-Sensitive Prodrug
摘要:提出了一种合成ph敏感前药的新方法:硫脲药物修饰.由此产生的前药能在肿瘤细胞酸性环境中释放出细胞毒素和生物活性2-硫乙内酰脲.通过fret模型验证了硫脲在酸性催化下环化成2-硫乙内酰脲的概念.获得了模型叠氮胸苷,细胞毒素阿霉素和2-硫乙内酰脲阿布妥因的双前药,在酸性环境中能释放相应的药物.对前列腺癌细胞进行了所得阿霉素前药的测试,结果显示硫脲修饰的前药在ph 7.6中性环境下比阿霉素(ic50范围为0.01258至0.02559 μm)的细胞毒性低(平均ic50范围为0.5584至0.9885 μm),而在癌细胞的轻度酸性条件下与阿霉素(ic50范围为0.2303至0.8110 μm)的毒性相似(平均ic50范围为0.4970至0.7994 μm).在pc3肿瘤细胞中,Dox前药的细胞内和核内积累远远高于游离阿霉素.
DOI:10.1021/acs.Bioconjchem.8B00885

海关参考信息

专利信息


专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

专利号:US-8017776-B2
优先权日:2003-07-15
标题 :Methods for synthesis of acyloxyalkyl compounds
发明人:BHAT LAXMINARAYAN; GALLOP MARK A
权利人:XENOPORT INC
摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

专利号:US-2015158809-A9
优先权日:2013-02-26
标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
权利人:XENOPORT INC
摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

专利号:US-2008214827-A1
优先权日:2004-02-03
标 题:Synthesis of Cyanoimino-Benzoimidazoles
发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
权利人:EURO CELTIQUE SA
摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

专利号:US-8143437-B2
优先权日:2002-02-19
标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

专利号:WO-2009094569-A2
优先权日:2008-01-25
标 题:Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Cereghino JJ, Brock JT, Van Meter JC, Penry JK, Smith LD, Fisher P, Ellenberg J. Evaluation of albutoin as an antiepileptic drug. Clin Pharmacol Ther. 1974 Apr;15(4):406-16.

合成参考文献


摘要:Toxicology and Applied Pharmacology., 3(107), 1961 []
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知